ReelCardio is an exciting new ambulatory cardiac (AECG) monitoring company built on a well-rounded & established foundation. ReelCardio already possesses proprietary product technology (called ReelECG™) strategic marketing expertise, worldwide distribution network, and all of the regulatory approvals – FDA approval ,CE Mark & TGA approval, Medicare approval as an Independent Diagnostic Testing Facility (IDTF). With all of the right ingredients formulated from the start of the company’s inception, ReelCardio has a distinct advantage to rapidly evolve to become the new worldwide leader & disrupt the ambulatory cardiac (AECG) monitoring industry.
The ReelCardio Team is not new to the ambulatory cardiac AECG monitoring. ReelCardio is simply a strategic merger of two unique & proprietary entities that deliver unique technology with a US based marketing & distribution powerhouse. In fact, the ReelCardio team has arguable more experience specific to AECG monitoring & cardiac rhythm management than any other team in our industry. Our team brings decades (20+ years) of specific cardiac monitoring market experience. Our product technology, distribution, regulatory approvals & ECG laboratory service experience has a far greater probability to overcome the ‘traditional obstacles’ of growth & success in one of the largest growing segments in worldwide medicine today. Remote cardiac monitoring & tele-health consultations are up more than 6000% in the last 3 years! This is a hotbed of activity in the investment community – all trying to find the right opportunity to ride this tidal wave of growth with this unique market opportunity!
Unlike the majority of a new AECG monitoring start-ups, ReelCardio is not starting from scratch (with just a idea). ReelCardio is an experienced & seasoned group with tremendous depth & experience to bypass the painful learning (curve) process. Traditional road blocks such as lack 0f real market knowledge, buying habits, business models, product technology, sales & distribution network, regulatory approvals & Medicare IDTF Approval. ReelCardio is ‘one-of-a- kind’ investment opportunity as we already possess all of these key components immediately from the company’s inception!
It is factual that the majority of start-up AECG companies do not succeed due to the daunting costs, time, inefficient use of investment capital, lack of market & regulatory experience to overcome the traditional ‘pit-falls’ to thrive in this ever-evolving market segment.
Remote patient Monitoring of ECG is one of the ‘hottest’ markets today for the savvy investment community. It is not surprise that with the current shift in market activity, market factors such as post pandemic, market confusion due to consolidation, that there is not better time to get involved with a unique opportunity to enter the explosive Mobile Cardiac Telemetry (MCT) market segment with the ReelCardio team.
In that spirit, the ReelCardio team is not new to the Ambulatory ECG monitoring space but rather a NEW entity. ReelCardio combines established, proprietary ReelECG™ AECG Monitoring Technology with the decades of US & worldwide market experience / expertise with all the necessary regulatory approvals. ReelCardio has the largest worldwide distribution network in the industry today. Our investors will enter this dynamic industry far ahead of many companies (certainly any start-up) with all of our market experience, intellectual property of today’s wearable, real-time AECG technology that already has acquired all of the necessary regulatory approvals. Such accreditations include FDA Market Clearance / Approval, CE Approval & even further, ReelCardio enters the industry as an accredited Medicare Approved Independent Diagnostic Testing Facility (IDTF). This saves years of time to market compared to the many companies in a waiting pattern to enter the US market.
It is critical to digest the fact that these regulatory accreditations are very time-consuming and ultimately debilitating to many of the startup AECG companies. They require a significant financial investment, time, expertise, good fortune that can deter many new AECG companies to enter the market. In addition, specific market investigation into most of the investment activity in our space, it will reveal that the majority of these new entities are from people from ‘outside’ the industry. ReelCardio offers the investment community a unique opportunity to get involved with outstanding technology, a productive & experienced team with the capability to disrupt the industry as it stands today.
For more information on explore investment and/or partnership opportunities, please Contact Us.